• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺囊性病变手术后新发糖尿病的发生率及危险因素:一项 MarketScan 研究。

Incidence and Risk Factors for New-Onset Diabetes Mellitus After Surgical Resection of Pancreatic Cystic Lesions: A MarketScan Study.

机构信息

From the Department of Internal Medicine.

Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center.

出版信息

Pancreas. 2022 May 1;51(5):427-434. doi: 10.1097/MPA.0000000000002054. Epub 2022 Jul 19.

DOI:10.1097/MPA.0000000000002054
PMID:35858183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9388590/
Abstract

OBJECTIVES

There is a paucity of literature evaluating new-onset diabetes mellitus (NODM) after resection of pancreatic cystic lesions (PCLs). We sought to characterize the incidence and risk factors associated with NODM after partial pancreatectomy for PCLs.

METHODS

We utilized the IBM MarketScan Database (2012-2018) to identify all nondiabetic adults who underwent partial pancreatectomy for PCLs. Patients with any other pancreatic disease were excluded. We performed Kaplan-Meier analysis and multivariable Cox proportional hazards regression to define the incidence and risk factors of postoperative NODM.

RESULTS

Among 311 patients, the overall risk (95% confidence interval) of NODM was 9.1% (6.3-12.9%), 15.1% (11.3-20.2%), and 20.2% (15.3-26.4%) at 6, 12 and 24 months, respectively. Multivariable analysis (adjusted hazard ratio; 95% confidence interval) revealed that older age (1.97; 1.04-3.72; 55-64 vs 18-54 years), obesity (2.63; 1.35-5.12), hypertension (1.79; 1.01-3.17), and cardiovascular disease (2.54; 1.02-6.28) were independent predictors of NODM. Rates of NODM were similar after distal pancreatectomy versus pancreaticoduodenectomy.

CONCLUSIONS

Within 2 years, 1 in 5 patients without any other pancreatic disease will develop NODM after partial pancreatectomy for PCLs. Those with advanced age, metabolic syndrome features, and/or cardiovascular disease may benefit from preoperative counseling and intensive postoperative monitoring, education, and treatment for diabetes mellitus.

摘要

目的

评估胰腺囊性病变(PCL)切除术后新发糖尿病(NODM)的文献很少。我们旨在研究胰腺部分切除术治疗 PCL 后发生 NODM 的发生率和相关风险因素。

方法

我们利用 IBM MarketScan 数据库(2012-2018 年)确定了所有因 PCL 而行胰腺部分切除术的非糖尿病成人患者。排除有任何其他胰腺疾病的患者。我们进行 Kaplan-Meier 分析和多变量 Cox 比例风险回归,以确定术后 NODM 的发生率和风险因素。

结果

在 311 例患者中,NODM 的总体风险(95%置信区间)分别为 9.1%(6.3-12.9%)、15.1%(11.3-20.2%)和 20.2%(15.3-26.4%),分别在 6、12 和 24 个月时。多变量分析(调整后的危险比;95%置信区间)显示,年龄较大(1.97;1.04-3.72;55-64 岁与 18-54 岁)、肥胖(2.63;1.35-5.12)、高血压(1.79;1.01-3.17)和心血管疾病(2.54;1.02-6.28)是 NODM 的独立预测因素。远端胰腺切除术与胰十二指肠切除术相比,NODM 的发生率相似。

结论

在 2 年内,每 5 例无其他胰腺疾病的患者中就有 1 例会在因 PCL 行胰腺部分切除术后发生 NODM。年龄较大、代谢综合征特征和/或心血管疾病的患者可能需要术前咨询,并在术后进行强化监测、教育和糖尿病治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc2/9388590/06035a9dfd4b/nihms-1810665-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc2/9388590/8431661e8dac/nihms-1810665-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc2/9388590/92f1ca271d9e/nihms-1810665-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc2/9388590/5d8d8f3339e1/nihms-1810665-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc2/9388590/06035a9dfd4b/nihms-1810665-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc2/9388590/8431661e8dac/nihms-1810665-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc2/9388590/92f1ca271d9e/nihms-1810665-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc2/9388590/5d8d8f3339e1/nihms-1810665-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc2/9388590/06035a9dfd4b/nihms-1810665-f0004.jpg

相似文献

1
Incidence and Risk Factors for New-Onset Diabetes Mellitus After Surgical Resection of Pancreatic Cystic Lesions: A MarketScan Study.胰腺囊性病变手术后新发糖尿病的发生率及危险因素:一项 MarketScan 研究。
Pancreas. 2022 May 1;51(5):427-434. doi: 10.1097/MPA.0000000000002054. Epub 2022 Jul 19.
2
Evaluation of allowable pancreatic resection rate depending on preoperative risk factors for new-onset diabetes mellitus after distal pancreatectomy.评估远端胰腺切除术后新发糖尿病的术前危险因素对允许胰腺切除率的影响。
Pancreatology. 2020 Oct;20(7):1526-1533. doi: 10.1016/j.pan.2020.08.005. Epub 2020 Aug 16.
3
Risk factors for new-onset diabetes mellitus after distal pancreatectomy.远端胰腺切除术后新发糖尿病的危险因素。
BMJ Open Diabetes Res Care. 2020 Oct;8(2). doi: 10.1136/bmjdrc-2020-001778.
4
New-Onset Diabetes Mellitus After Distal Pancreatectomy: A Systematic Review and Meta-Analysis.胰体尾切除术后新发糖尿病:一项系统评价与荟萃分析。
J Laparoendosc Adv Surg Tech A. 2020 Nov;30(11):1215-1222. doi: 10.1089/lap.2020.0090. Epub 2020 Jun 18.
5
New-onset diabetes after distal pancreatectomy: a systematic review.胰体尾切除术后新发糖尿病:一项系统评价
Ann Surg. 2015 May;261(5):854-61. doi: 10.1097/SLA.0000000000000819.
6
Clinical utility of resected pancreatic volume ratio calculation for predicting postoperative new-onset diabetes mellitus after distal pancreatectomy-a propensity-matched analysis.切除胰腺体积比计算对预测远端胰腺切除术后新发糖尿病的临床效用——一项倾向匹配分析
Heliyon. 2023 May 3;9(5):e15998. doi: 10.1016/j.heliyon.2023.e15998. eCollection 2023 May.
7
Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.减少他克莫司用量可降低肝移植后新发糖尿病的风险。
World J Gastroenterol. 2016 Feb 14;22(6):2133-41. doi: 10.3748/wjg.v22.i6.2133.
8
Prevalence and Risk Factors for Pancreatic Insufficiency After Partial Pancreatectomy.胰腺部分切除术后胰腺功能不全的患病率及危险因素
J Gastrointest Surg. 2022 Jul;26(7):1425-1435. doi: 10.1007/s11605-022-05302-3. Epub 2022 Mar 22.
9
New-Onset Diabetes Mellitus in Liver Transplant Recipients With Hepatitis C: Analysis of the National Database.丙型肝炎肝移植受者新发糖尿病:全国数据库分析
Transplant Proc. 2016 Jan-Feb;48(1):138-44. doi: 10.1016/j.transproceed.2015.11.010.
10
New-Onset Diabetes Is a Potential Marker for the Malignant Transformation of Pancreatic Cysts: A Real-World Population Cohort Study.新诊断糖尿病是胰腺囊肿恶性转化的一个潜在标志物:一项真实世界人群队列研究。
Pancreas. 2022 Oct 1;51(9):1186-1193. doi: 10.1097/MPA.0000000000002161.

引用本文的文献

1
Evolving techniques in the endoscopic evaluation and management of pancreas cystic lesions.胰腺囊性病变内镜评估与管理的技术进展
Curr Opin Gastroenterol. 2025 Sep 1;41(5):339-347. doi: 10.1097/MOG.0000000000001119. Epub 2025 Jul 16.
2
Current Endoscopic and Surgical Management of Pancreatic Cystic Lesions: A Comprehensive Review.胰腺囊性病变的当前内镜及手术治疗:一项全面综述
Turk J Gastroenterol. 2024 Nov 4;36(1):6-14. doi: 10.5152/tjg.2024.24124.
3
Challenges of Managing Type 3c Diabetes in the Context of Pancreatic Resection, Cancer and Trauma.
胰腺切除、癌症和创伤背景下3c型糖尿病管理面临的挑战
J Clin Med. 2024 May 19;13(10):2993. doi: 10.3390/jcm13102993.
4
Novel Insights into Postoperative Surveillance in Resected Pancreatic Cystic Neoplasms-A Review.胰腺囊性肿瘤切除术后监测的新见解——综述
Diagnostics (Basel). 2024 May 19;14(10):1056. doi: 10.3390/diagnostics14101056.
5
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions.《香港关于胰腺囊性病变诊断与管理的共识建议》
Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):715-735. doi: 10.21037/hbsn-22-471. Epub 2023 Jul 6.
6
Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors-a Systematic Review and Meta-analysis of Surgery-Associated Morbidity.保留十二指肠的胰头切除术治疗良恶性肿瘤:手术相关并发症的系统评价和荟萃分析。
J Gastrointest Surg. 2023 Nov;27(11):2611-2627. doi: 10.1007/s11605-023-05789-4. Epub 2023 Sep 5.